Navigation Links
Global Biologic Drugs Market to Jump to Over $220 Billion by 2019 says Latest Report
Date:11/21/2013

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/q6n3x8/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Biologics, also known as biopharmaceuticals, can be categorized into three main modalities: therapeutic proteins, monoclonal antibodies and vaccines. Most of the biologic drugs marketed so far are recombinant therapeutic protein drugs, which are used to relieve patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular diseases, infertility and cystic fibrosis. Globally, the U.S. commands 43% of biologics sales, followed by the E.U. (21%) and Japan (9%).

The "Expanding Markets for Biologics and Biosimilars" report covers key biologic and biosimilar drugs, including:

  • Humira (Adalimumab)
  • Remicade (Infliximab)
  • Lantus (Insulin Glargine)
  • Levemir (Insulin Detemir)
  • Privigen (Immune Globulin Intravenous)
  • Perjeta (Pertuzumab)
  • Soliris (Eculizumab)
  • Eylea (Aflibercept)
  • Revlimid (Lenalidomide)
  • Herceptin (Trastuzumab)
  • Gardasil
  • Varivax (Varicella Virus Vaccine Live)
  • Gammagard Liquid (Immune Globulin Infusion (Human))
  • Aranesp (Darbepoetin Alfa)
  • Enbrel (Etanercept)
  • Epogen/Procrit/Eprex/Erypo (Epoetin Alfa)
  • Genotropin (Somatropin)
  • Herceptin (Trastuzumab)
  • Humira (Adalimumab)
  • Neulasta (Pegfilgrastim)
  • Neupogen (Filgrastim)
  • Remicade (Infliximab)
  • Rituxan/MabThera (Rituximab)

The "Expanding Markets for Biologics and Biosimilars" report examines companies manufacturing biologic and biosimilar equipment and supplies in the world.

Companies covered include:

- AbbVie, Inc
- Abbott Laboratories
- Actelion Ltd
- Amgen, Inc
- Amoytop Biotech Co, Ltd
- Anhui Anke Biotechnology (Group) Co, Ltd
- Apotex, Inc
- Astellas Pharma, Inc
- AstraZeneca
- Bayer AG
- Beijing Four Rings Biopharmaceuticals
- Bharat Serums and Vaccines Limited
- Bio, Inc
- Biocon Ltd
- Biogen Idec, Inc
- Bioton SA
- Boehringer Ingelheim Pharmaceuticals, Inc
- Bristol-Myers Squibb, Co
- Celgene Corporation
- Celltrion, Inc
- Cipla Ltd
- Dr Reddy's Laboratories Ltd
- Elan Corporation, PLC
- Eli Lilly & Co
- Gideon Richter
- Gilead Sciences, Inc
- GlaxoSmithKline PLC
- Hospira, Inc
- Intas Pharmaceuticals Limited
- Johnson & Johnson
- Merck & Co, Inc
- Mylan, Inc
- Novartis AG
- Pfizer, Inc
- Roche Holdings AG
- Sandoz International GmbH
- Sanofi
- Stada Arzneimittel Aktiengesellschaft
- Teva Pharmaceutical Industries Limited
- Watson Pharmaceuticals, Inc 

Detailed charts with sales forecasts and marketshare data are included.

For more information visit http://www.researchandmarkets.com/research/q6n3x8/biologics_and

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. High Temperature Plastics - Making Conventional Material Obsolete - Global Strategic Business Report 2013
2. Neurology Devices Market (CSF Shunts, CSF Drainage, Clot Retriever, Snare, Embolic Coil, Flow Diversion, Neurosurgery & Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
3. Global Medical Antimicrobial Coatings Market 2012-2016
4. Ophthalmic Instrumentation - Global Strategic Business Report - 2012 Featuring Abbott, Bausch & Lomb, Carl Zeiss and Others
5. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
6. Blood Processing Supplies and Equipment - Global Strategic Business Report
7. Intravenous Equipment - Global Strategic Business Report
8. Global Medical Laser Systems Market Report 2013-2018: Global Aesthetics Laser Market Poised to Grow
9. Global Coagulation Self-Testing Devices, Markets, Players and Prospects Report 2013
10. Global Point-of-Delivery Drug Reconstitution Systems Market Report 2013 - 2017
11. Noser Engineering AG Expand Medical Device Technology Offering Meeting the Needs of Global Regulatory Compliance and Accelerating Time to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - Industry Forecast to 2025" report to their offering. ... The Global Wireless ... 23.8% over the next decade to reach approximately $330.5 billion by ... forecasts for all the given segments on global as well as ...
(Date:2/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Hemophilia market? What are ...
(Date:2/24/2017)... 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... release, you are invited to listen to a conference ... on Tuesday, March 14, 2017 at 4:30 pm Eastern ... audio webcast of the presentation will be available by ... "Investor Relations."  If you are unable to participate during ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata ... Spiritual Awakening, is happy to announce her “Spring Rejuvenation in Sedona” personally ... individual customized retreats offer the winter-weary soul an excellent opportunity to come out ...
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based ... In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... company had 800 customers and 2,250 RCEs at the time of acquisition. In ...
(Date:2/27/2017)... ... ... New Jersey ranks among the top five states in the entire nation ... advanced services is growing. , Project WE vs C is a focused two-year ... non-profit partners in their fight against cancer and in support of their shared mission ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care ... Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade to its ... look for home care close to home, and by having city-specific pages, NuevaCare is ...
Breaking Medicine News(10 mins):